• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.通过实体瘤标本、含肿瘤的腹腔渗出细胞、肿瘤浸润淋巴细胞(TIL)衍生的T细胞系和已建立的肿瘤细胞系,检测人上皮性卵巢癌中细胞因子转录本的差异表达。
Clin Exp Immunol. 1998 May;112(2):172-80. doi: 10.1046/j.1365-2249.1998.00576.x.
2
Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.腹腔注射重组干扰素-γ和重组白细胞介素2(伴或不伴肿瘤浸润淋巴细胞)对卵巢癌或腹膜癌患者的临床及生物学效应
Clin Cancer Res. 2000 Jun;6(6):2268-78.
3
Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.源自卵巢癌患者肿瘤浸润淋巴细胞的T细胞系产生的细胞因子:肿瘤特异性免疫反应及卵巢肿瘤细胞对抗抗原非依赖性细胞因子产生的抑制作用
Lymphokine Cytokine Res. 1993 Dec;12(6):429-37.
4
Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells.在卵巢癌患者恶性腹水中鉴定出一种产生白细胞介素-10的HLA-DR阴性单核细胞亚群,该亚群可抑制细胞因子蛋白表达和自体T细胞增殖。
J Immunol. 1999 Dec 1;163(11):6251-60.
5
Functional and molecular characterization of tumour-infiltrating lymphocytes and clones thereof from a major-histocompatibility-complex-negative human tumour: neuroblastoma.来自主要组织相容性复合体阴性人类肿瘤(神经母细胞瘤)的肿瘤浸润淋巴细胞及其克隆的功能和分子特征
Cancer Immunol Immunother. 1996 Mar;42(3):170-8. doi: 10.1007/s002620050267.
6
Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.人肾细胞癌中新鲜(未培养)肿瘤浸润性T淋巴细胞的表型、细胞因子产生及细胞溶解能力
Clin Exp Immunol. 1997 Sep;109(3):501-9. doi: 10.1046/j.1365-2249.1997.4771375.x.
7
Transduction of rIL-2 expanded CD4+ and CD8+ ovarian TIL-derived T cell lines with the G1Na (neor) replication-deficient retroviral vector.用G1Na(新霉素抗性基因)复制缺陷型逆转录病毒载体转导重组白细胞介素-2扩增的CD4+和CD8+卵巢肿瘤浸润淋巴细胞来源的T细胞系。
Hum Gene Ther. 1995 Nov;6(11):1379-89. doi: 10.1089/hum.1995.6.11-1379.
8
Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancer.与肾细胞癌患者外周淋巴细胞相比,CD4(+)或CD8(+)肿瘤浸润淋巴细胞中IFN-γ mRNA表达增强。
Br J Cancer. 2000 Sep;83(5):637-41. doi: 10.1054/bjoc.2000.1275.
9
Expression of cytokine mRNA transcripts in renal cell carcinoma.细胞因子mRNA转录本在肾细胞癌中的表达
Immunol Cell Biol. 1998 Aug;76(4):357-62. doi: 10.1046/j.1440-1711.1998.00759.x.
10
Characterization of tumor-infiltrating lymphocyte subsets from human renal cell carcinoma: specific reactivity defined by cytotoxicity, interferon-gamma secretion, and proliferation.人肾细胞癌肿瘤浸润淋巴细胞亚群的特征:由细胞毒性、γ-干扰素分泌和增殖所定义的特异性反应
J Immunother Emphasis Tumor Immunol. 1994 Feb;15(2):91-104. doi: 10.1097/00002371-199402000-00002.

引用本文的文献

1
Clonally expanded alpha-chain T-cell receptor (TCR) transcripts are present in aneurysmal lesions of patients with Abdominal Aortic Aneurysm (AAA).在患有腹主动脉瘤 (AAA) 的患者的动脉瘤病变中存在克隆扩增的α-链 T 细胞受体 (TCR) 转录本。
PLoS One. 2019 Jul 16;14(7):e0218990. doi: 10.1371/journal.pone.0218990. eCollection 2019.
2
The Mesothelial Origin of Carcinoma Associated-Fibroblasts in Peritoneal Metastasis.腹膜转移中癌相关成纤维细胞的间皮起源
Cancers (Basel). 2015 Sep 29;7(4):1994-2011. doi: 10.3390/cancers7040872.
3
Tumor infiltrating lymphocytes in ovarian cancer.卵巢癌中的肿瘤浸润淋巴细胞
Cancer Biol Ther. 2015;16(6):807-20. doi: 10.1080/15384047.2015.1040960. Epub 2015 Apr 20.
4
Overexpression and immunosuppressive functions of transforming growth factor 1, vascular endothelial growth factor and interleukin-10 in epithelial ovarian cancer.上皮性卵巢癌中转化生长因子 1、血管内皮生长因子和白细胞介素 10 的过表达及其免疫抑制功能。
Chin J Cancer Res. 2012 Jun;24(2):130-7. doi: 10.1007/s11670-012-0130-y.
5
IL-10 immunomodulation of myeloid cells regulates a murine model of ovarian cancer.白细胞介素-10 对髓样细胞的免疫调节作用调控了卵巢癌的小鼠模型。
Front Immunol. 2011 Jul 21;2:29. doi: 10.3389/fimmu.2011.00029. eCollection 2011.
6
IL-4 induces cathepsin protease activity in tumor-associated macrophages to promote cancer growth and invasion.IL-4 诱导肿瘤相关巨噬细胞中的组织蛋白酶蛋白酶活性,从而促进癌症生长和侵袭。
Genes Dev. 2010 Feb 1;24(3):241-55. doi: 10.1101/gad.1874010. Epub 2010 Jan 15.
7
Immunological profiling of a panel of human ovarian cancer cell lines.一组人卵巢癌细胞系的免疫分析
Cancer Immunol Immunother. 2008 Jan;57(1):31-42. doi: 10.1007/s00262-007-0347-7. Epub 2007 Jun 20.
8
Monocyte/macrophage and T-cell infiltrates in peritoneum of patients with ovarian cancer or benign pelvic disease.卵巢癌或良性盆腔疾病患者腹膜中的单核细胞/巨噬细胞和T细胞浸润。
J Transl Med. 2006 Jul 6;4:30. doi: 10.1186/1479-5876-4-30.
9
Ovarian cancer, the coagulation pathway, and inflammation.卵巢癌、凝血途径与炎症
J Transl Med. 2005 Jun 21;3:25. doi: 10.1186/1479-5876-3-25.
10
Peritoneal inflammation - A microenvironment for Epithelial Ovarian Cancer (EOC).腹膜炎症——上皮性卵巢癌(EOC)的微环境。
J Transl Med. 2004 Jun 25;2(1):23. doi: 10.1186/1479-5876-2-23.

本文引用的文献

1
Lineage-negative human leukocyte antigen-DR+ cells with the phenotype of undifferentiated dendritic cells in patients with carcinoma of the abdomen and pelvis.腹部和盆腔癌患者中具有未分化树突状细胞表型的谱系阴性人类白细胞抗原-DR+细胞。
Clin Cancer Res. 1998 Mar;4(3):799-809.
2
Immunopharmacology and cytokine production of a low-dose schedule of intraperitoneally administered human recombinant interleukin-2 in patients with advanced epithelial ovarian carcinoma.腹腔内低剂量注射人重组白细胞介素-2治疗晚期上皮性卵巢癌患者的免疫药理学及细胞因子产生情况
J Immunother Emphasis Tumor Immunol. 1996 Nov;19(6):443-51. doi: 10.1097/00002371-199611000-00009.
3
HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.人卵巢癌细胞上的HLA I类分子表达与体内T细胞浸润以及在低浓度重组白细胞介素-2条件下体外T细胞扩增相关。
Cell Immunol. 1996 Dec 15;174(2):116-28. doi: 10.1006/cimm.1996.0301.
4
Immunotherapy for peritoneal ovarian carcinoma metastasis using ex vivo expanded tumor infiltrating lymphocytes.使用体外扩增的肿瘤浸润淋巴细胞对腹膜卵巢癌转移进行免疫治疗。
Cancer Treat Res. 1996;82:115-46. doi: 10.1007/978-1-4613-1247-5_8.
5
IL-10 inhibits nuclear factor-kappa B/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes.白细胞介素-10抑制CD3刺激的人外周血T淋巴细胞中核因子-κB/Rel的核活性。
J Immunol. 1996 Mar 15;156(6):2119-23.
6
Intraperitoneal recombinant interferon gamma in ovarian cancer patients with residual disease at second-look laparotomy.二次剖腹探查术时腹腔内注射重组干扰素γ用于卵巢癌残留病灶患者。
J Clin Oncol. 1996 Feb;14(2):343-50. doi: 10.1200/JCO.1996.14.2.343.
7
Negative regulation of cell growth by TGF beta.转化生长因子β对细胞生长的负调控
Biochim Biophys Acta. 1996 Mar 18;1242(3):185-99. doi: 10.1016/0304-419x(95)00009-5.
8
Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-beta and nitric oxide.肿瘤诱导的产生转化生长因子-β和一氧化氮的粒细胞-巨噬细胞祖细胞对T细胞增殖的抑制作用。
J Immunol. 1996 Mar 1;156(5):1916-22.
9
Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer.卵巢上皮癌患者血清及腹水中白细胞介素-1、白细胞介素-6和肿瘤坏死因子-α的水平
Cancer. 1993 Oct 15;72(8):2433-40. doi: 10.1002/1097-0142(19931015)72:8<2433::aid-cncr2820720822>3.0.co;2-l.
10
Large-scale expansion in interleukin-2 of tumor-infiltrating lymphocytes from patients with ovarian carcinoma for adoptive immunotherapy.对卵巢癌患者的肿瘤浸润淋巴细胞进行白细胞介素-2大规模扩增以用于过继性免疫治疗。
J Immunol Methods. 1994 Jan 3;167(1-2):145-60. doi: 10.1016/0022-1759(94)90084-1.

通过实体瘤标本、含肿瘤的腹腔渗出细胞、肿瘤浸润淋巴细胞(TIL)衍生的T细胞系和已建立的肿瘤细胞系,检测人上皮性卵巢癌中细胞因子转录本的差异表达。

Differential expression of cytokine transcripts in human epithelial ovarian carcinoma by solid tumour specimens, peritoneal exudate cells containing tumour, tumour-infiltrating lymphocyte (TIL)-derived T cell lines and established tumour cell lines.

作者信息

Nash M A, Lenzi R, Edwards C L, Kavanagh J J, Kudelka A P, Verschraegen C F, Platsoucas C D, Freedman R S

机构信息

Department of Gynecological Oncology, The University of Texas, M. D. Anderson Cancer Center, Houston 77030, USA.

出版信息

Clin Exp Immunol. 1998 May;112(2):172-80. doi: 10.1046/j.1365-2249.1998.00576.x.

DOI:10.1046/j.1365-2249.1998.00576.x
PMID:9649178
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1904977/
Abstract

T cell lines derived in low concentrations of recombinant IL-2 (rIL-2) from TIL of patients with epithelial ovarian carcinoma (EOC) often exhibit specific cytotoxicity against autologous tumour cells. However, the ability of T cells at the tumour site to respond to ovarian carcinoma cells may be affected by the production of cytokines by the various cell types present. Using reverse transcriptase-polymerase chain reaction (RT-PCR) we investigated cytokine transcripts in: (i) established EOC tumour cell lines; (ii) solid tumour specimens or peritoneal exudate cells (PEC) from ascites or peritoneal washings of patients with EOC; and (iii) CD4+ TCRalphabeta+ and CD8+ TCRalphabeta+ TIL-derived T cell lines developed in rIL-2. We have found that (i) established EOC tumour cell lines expressed transcripts for transforming growth factor-beta 2 (TGF-beta2) (7/7), but not IL-10 (0/7) or interferon-gamma (IFN-gamma) (0/7) and rarely IL-2 (1/7); (ii) PEC expressed transcripts for IL-2 (12/13), IL-10 (9/13), and TGF-beta2 (12/13), and less often, IFN-gamma (3/13), whereas solid tumour specimens from eight patients with EOC expressed transcripts for IL-2 (4/8), TGF-beta2 (4/8), and IL-10 (5/8), but not for IFN-gamma (0/8); (iii) CD4+ TCRalphabeta+ T cell lines expressed transcripts for IFN-gamma (4/4), IL-2 (4/4) and IL-10 (3/4), whereas CD8+ TCRalphabeta+ T cell lines expressed transcripts for IFN-gamma (5/5), IL-2 (1/5) and IL-10 (2/5). None of these T cell lines expressed TGF-beta2 transcripts. The frequency of IL-2 and TGF-beta2 transcripts in solid tumours was significantly lower than in the PEC (P = 0.0475). CD4+ or CD8+ T cell lines expressing IFN-gamma, IL-2 and IL-10 transcripts were derived in culture with rIL-2 from the TIL of specimens that did not necessarily express these cytokines in the absence of rIL-2. The frequency of cytokine transcripts in T cell lines compared with these same transcripts in the PEC was significantly higher for IFN-gamma (P = 0.0005) and lower for TGF-beta2 (P = 0.0001). An association was observed between the expression of cytokine transcripts in vivo or by TIL-derived cell lines and functions exhibited by either production of cytokines or in vitro cytotoxicity.

摘要

从上皮性卵巢癌(EOC)患者的肿瘤浸润淋巴细胞(TIL)中,在低浓度重组白细胞介素-2(rIL-2)条件下衍生出的T细胞系,常常表现出针对自体肿瘤细胞的特异性细胞毒性。然而,肿瘤部位的T细胞对卵巢癌细胞作出反应的能力,可能会受到存在的各种细胞类型所产生的细胞因子的影响。我们使用逆转录聚合酶链反应(RT-PCR),研究了以下样本中的细胞因子转录本:(i)已建立的EOC肿瘤细胞系;(ii)EOC患者腹水或腹腔灌洗的实体瘤标本或腹腔渗出细胞(PEC);以及(iii)在rIL-2中培养出的CD4+ TCRαβ+和CD8+ TCRαβ+ TIL衍生的T细胞系。我们发现:(i)已建立的EOC肿瘤细胞系表达转化生长因子-β2(TGF-β​​2)的转录本(7/7),但不表达白细胞介素-10(IL-10)(0/7)或干扰素-γ(IFN-γ)(0/7),很少表达IL-2(1/7);(ii)PEC表达IL-2(12/13)、IL-10(9/13)和TGF-β​​2(12/13)的转录本,较少表达IFN-γ(3/13),而8例EOC患者的实体瘤标本表达IL-2(4/8)、TGF-β​​2(4/8)和IL-10(5/8)的转录本,但不表达IFN-γ(0/8);(iii)CD4+ TCRαβ+ T细胞系表达IFN-γ(4/4)、IL-2(4/4)和IL-10(3/4)的转录本,而CD8+ TCRαβ+ T细胞系表达IFN-γ(5/5)、IL-2(1/5)和IL-10(2/5)的转录本。这些T细胞系均未表达TGF-β​​2转录本。实体瘤中IL-2和TGF-β​​2转录本的频率显著低于PEC中的频率(P = 0.0475)。表达IFN-γ​​、IL-2和IL-10转录本CD4+或CD8+ T细胞系,是在含有rIL-2的培养物中,从TIL标本衍生而来,这些标本在不存在rIL-2的情况下不一定表达这些细胞因子。与PEC中相同转录本相比,T细胞系中细胞因子转录本的频率,IFN-γ更高(P = 0.0005),TGF-β​​2更低(P = 0.0001)。观察到体内或TIL衍生细胞系中细胞因子转录本的表达,与通过细胞因子产生或体外细胞毒性所表现出的功能之间存在关联。